论文:以第一及通讯作者发表论文40余篇,代表性学术论文如下 1. YAP inhibitor verteporfin suppresses tumor angiogenesis and overcomes chemoresistance in esophageal squamous cell carcinoma. J Cancer Res Clin Oncol. 2023;149(10):7703-7716. 2. IQGAP1 enhances cell invasion and matrix metalloproteinase-2 expression through upregulating NF-κB activity in esophageal squamous cell carcinoma cells. Gene. 2022;824:146406. 3. miR-4306 suppresses proliferation of esophageal squamous cell crcinoma cell by targeting SIX3. Cell Biochem Biophys. 2021;79(4):769-779. 4. Aurora kinase inhibitor VX-680 enhances sensitivity of esophageal squamous cell carcinoma cells to cisplatin chemotherapy. Anticancer Drugs. 2021;32(9):969-977. 5. Aurora-A modulates MMP-2 expression via AKT/NF-κB pathway in esophageal squamous cell carcinoma cells. Acta Biochim Biophys Sin (Shanghai). 2016;48(6):520-527. 6. Aurora-A enhances malignant development of esophageal squamous cell carcinoma (ESCC) by phosphorylating β-catenin. Mol Oncol. 2015;9(1):249-259. 7. Overexpression of Aurora-A kinase promotes tumor cell proliferation and inhibits apoptosis in esophageal squamous cell carcinoma cell line. Cell Research. 2006; 16: 356-366. 专利:以第一发明人获得发明专利授权2项 |